ADIPOQ and Alzheimer disease: Recently, several studies reported that HOMA-IR has some limitations in predicting insulin resistance in certain populations (18, 19), therefore two adiponectin-based methods were developed; the HOMA corrected by adiponectin (HOMA-AD) and leptin to Adiponectin ratio (LAR) (20, 21).